Please Wait...

Harrison Clinical Research Selects BioClinica OnPoint CTMS

– Leading European CRO Chooses 'Flexible and Affordable' Clinical Trial Management (CTMS) Technology –

January 17, 2012

January 17, 2012.  NEWTOWN, PA – BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management solutions, announced today a new agreement with Harrison Clinical Research (HCR), an international full-service contract research organization. After notification that support for its previous CTMS solution would be discontinued, Harrison selected BioClinica OnPoint CTMS to replace that system. HCR decided that OnPoint is the best-in-class solution to provide services to its world-wide client base. Harrison currently supports approximately 80 clinical trials for its clients annually.

"After an extensive product search, we were impressed with BioClinica's technology and the operational efficiencies that it affords," said Monika Huber, Group Compliance Manager and Project Director of Harrison Clinical Research. "A robust CTMS system is critical for us to support trial management and optimal communication with our clients. Both our IT and clinical teams liked BioClinica's team and the technology, and in particular, how flexible and affordable it was compared to other solutions. BioClinica's product roadmap for OnPoint convinced us that it is the right partner for the long haul."

Harrison's in-depth selection process included a pilot project that offered users hands-on validation of OnPoint's capabilities and ease-of-use. "Harrison was already a Microsoft® SharePoint® customer," said Ms. Huber, "and when we saw the offline capabilities – through OnPoint to Outlook and Microsoft Office – we were even more impressed." BioClinica OnPoint leverages native connectivity through SharePoint to extend workflow management to Microsoft Office applications which allow end users to do much of their work using their familiar desktop applications.

"BioClinica is delighted to be chosen by Harrison Clinical Research for its world-wide clinical trial management needs after such a thorough selection process," said Peter Benton, President of eClinical Solutions for BioClinica. "Since launching the latest release of the product eight months ago, we have seen tremendous interest in OnPoint's ability to support global research combined with the flexibility sponsors need to create more efficient eClinical environments."

BioClinica OnPoint CTMS capabilities include: clinical site, personnel, patient and clinical supplies administration; scheduling, tracking and performance monitoring; site payments, study document management; and more. OnPoint CTMS is supported by Microsoft SharePoint and BioClinica technologies to provide superior team collaboration, connectivity and efficiency for multi-site implementations.

About the Harrison Clinical Research Group
Harrison Clinical Research (HCR) is an international contract research organization offering full service clinical research capabilities to the pharmaceutical industry. With Phase I (clinical pharmacology unit in Munich, Germany) to Phase IV capabilities, HCR focuses on providing the services our clients require for the successful clinical development and registration of new pharmaceutical, biological and nutraceuticals products as well as medical devices by delivering the highest quality data, achieving promised enrollment and meeting project timelines.

About Bioclinica

Bioclinica is a global life sciences solution provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval.  The company’s cloud-based offerings include medical imaging; cardiac safety; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site payments and forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers an integrated App xChange partner ecosystem, a global network of research sites, patient recruitment services, and post-approval research expertise to provide committed, detail-focused service through all stages of drug development.  The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Great advice from our Dir. Cardiovascular Imaging on how to achieve top quality imaging acquisitions & assessments… https://t.co/P57970FrOf
bioclinica (18 hours ago)
RT @CenterWatch: #CWWeekly: The increasing trend of adopting digital health and #mhealth apps for patient care. Read more, https://t.co/wo9…
bioclinica (19 hours ago)
RT @CenterWatch: Examining the difference between #patient engagement & patient recruitment. Read more in #CWPulse by @AshleyTointon, https…
bioclinica (19 hours ago)
RT @CenterWatch: How can #socialmedia play a role in health disparities and #clinicaltrial patient recruitment? Read more in #CWPulse by @A…
bioclinica (19 hours ago)
RT @RAPSorg: What New @FDAcdrhIndustry Guidance is Coming in FY 2018: Alternative 510(k) Pathway and More | #Regulatory Recon https://t.co/…
bioclinica (19 hours ago)
RT @RAPSorg: .@US_FDA Finalizes Guidance on Promotional Drug Labeling and Ads | #Regulatory Focus https://t.co/2rmtTWajlf #FDA #pharma
bioclinica (19 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices